Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12109234 Anti-BCMA CAR T cell compositions

Patent 12109234 was granted and assigned to 2seventy bio, Inc. on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
2seventy bio, Inc.
2seventy bio, Inc.
0
Date Filed
November 3, 2017
0
Date of Patent
October 8, 2024
0
Patent Applicant
2seventy bio, Inc.
2seventy bio, Inc.
0
Patent Application Number
16346393
0
Patent Citations
‌
US Patent 7067318 Methods for transfecting T cells
0
‌
US Patent 7144575 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 7172869 Methods for transfecting T cells
0
‌
US Patent 6867041 Simultaneous stimulation and concentration of cells
0
‌
US Patent 6887466 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 6905680 Methods of treating HIV infected subjects
0
‌
US Patent 6905681 Methods for selectively stimulating proliferation of T cells
0
‌
US Patent 6905874 Simultaneous stimulation and concentration of cells
0
‌
US Patent 7754482 Artificial antigen presenting cells and uses therefor
0
‌
US Patent 7977095 Generation and isolation of antigen-specific T cells
0
•••
Patent Inventor Names
Travis Quigley
0
Robert Ross
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12109234
0
Patent Primary Examiner
‌
Jessica H Roark
0
CPC Code
‌
A61K 9/0019
0
‌
A61K 2039/5156
0
‌
A61K 38/1774
0
‌
A61P 35/00
0
‌
A61P 7/00
0
‌
A61P 35/02
0
‌
C07K 14/7051
0
‌
C07K 14/70517
0
‌
C07K 14/70578
0
‌
C07K 16/2878
0
•••

Find more entities like US Patent 12109234 Anti-BCMA CAR T cell compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.